A recently approved immunization drug is helping to limit the severity of a respiratory disease that afflicts young children ...
The following is a summary of “Parent Perspectives on Nirsevimab for Their Newborn,” published in the November 2024 issue of ...
RSV is the most common cause of hospitalization in infants under 1 year old. The infection can spread to the lungs and cause ...
IDWeek 2024 was held at the Los Angeles Convention Center in Downtown Los Angeles, CA, USA, from 16–19 October. Phoebe Hall ...
Seasonal maternal respiratory syncytial virus vaccination and nirsevimab for infants demonstrate cost-effectiveness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback